Literature DB >> 4026495

Removal of therapeutic drugs by continuous arteriovenous hemofiltration.

T A Golper, J Pulliam, W M Bennett.   

Abstract

Plasma and ultrafiltrate drug concentrations were determined for 17 drugs in ten patients receiving continuous arteriovenous hemofiltration. Ultrafiltrate concentrations were not always predictable because of multiple factors, which may include altered drug-protein binding in these very ill patients.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4026495

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


  11 in total

Review 1.  Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients.

Authors:  T A Golper; W M Bennett
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 2.  Atracurium and laudanosine pharmacokinetics in acute renal failure.

Authors:  J M Hunter
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

3.  Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.

Authors:  I Tegeder; F Bremer; R Oelkers; H Schobel; J Schüttler; K Brune; G Geisslinger
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

4.  Pharmacokinetics of vancomycin during continuous hemodiafiltration.

Authors:  C Santré; O Leroy; M Simon; H Georges; B Guery; C Beuscart; G Beaucaire
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  Experience with brulamycin therapy in dialysed patients.

Authors:  L Löcsey; E Faragó; G Kakuk
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 6.  Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.

Authors:  Michael A Veltri; Alicia M Neu; Barbara A Fivush; Rulan S Parekh; Susan L Furth
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Effect of orally administered activated charcoal on vancomycin clearance.

Authors:  R L Davis; R A Roon; J R Koup; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

Review 8.  Clinical pharmacokinetics during continuous haemofiltration.

Authors:  F Bressolle; J M Kinowski; J E de la Coussaye; N Wynn; J J Eledjam; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

9.  Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.

Authors:  J Scholz; M Schulz; M Steinfath; S Höver; H Bause
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

Review 10.  A review of continuous renal replacement therapy.

Authors:  C G Flynn
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.